Tagraxofusp in combination with pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma shows encouraging preliminary efficacy with a manageable safety profile
Haematologica. 2024 Oct 3.
doi: 10.3324/haematol.2024.285380.
Online ahead of print.